Home > Boards > US OTC > Delisted > Immtech Pharmaceuticals (fka IMMP)

David Fleet Joins Immtech Board of Directors

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
cocktails and dreamz Member Profile
Followed By 57
Posts 5,162
Boards Moderated 2
Alias Born 08/03/07
160x600 placeholder
cocktails and dreamz   Saturday, 09/29/07 10:48:49 AM
Re: cocktails and dreamz post# 3
Post # of 39 
David Fleet Joins Immtech Board of Directors

NEW YORK, Aug. 28 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (AMEX: IMM) is pleased to announce that David Fleet has joined the Company's Board of Directors. Mr. Fleet has over 35 years of experience in the international pharmaceutical industry with proven success in business development, sales and marketing, manufacturing and technical roles in the U.S., Japan, Europe, and the Middle East. He has consulted for King Pharmaceuticals, Inc., Aspen Pharmacare Ltd., Living Cell Technologies Ltd., and Trigen AG. Mr. Fleet has also consulted for Vestar Capital Partners, MPM Capital, Bear Stearns, and Warburg Pincus, and he is a Non-Executive Director of OnMedica Group Ltd., a leading European physician internet website.

Mr. Fleet stated, 'I am impressed by Immtech's achievements and excited by the Company's growth opportunities. I look forward to working closely with the Immtech team to enhance shareholders' value.'

From 1997 to 2002 Mr. Fleet was SVP of Global Business Development for Innovex Ltd. - Quintiles Transnational. In that role he was responsible for global business development across all services and led more than 10 global account teams for major pharmaceutical customers. From 1993 to 1996 he was a founding shareholder of Innovex, responsible for global business development and establishment of principal subsidiaries in Germany, the U.S., and Japan. Mr. Fleet also spent 10 years at Schering-Plough, where he was responsible for various operations, including development and growth of the ethical and OTC products business as Area Director for Middle East and Africa. He was also manager of Schering-Plough's third largest pharmaceutical plant in Europe with responsibility for manufacturing operations for a full range of pharmaceutical products.

Mr. Fleet began his career at Ward Blenkinsop & Co., Ltd., a division of Boehringer Ingelheim, and was also with Major & Company Manufacturing, where he had managerial responsibilities over multiple pharmaceutical plants with large local and expatriate staff in West Africa. In addition to Mr. Fleet's global business development and management skills, he has extensive experience in negotiating with government agencies including the Department of Health from the United Kingdom, and European, Middle East and African Ministries of Health.

Eric L. Sorkin, Immtech's Chairman and Chief Executive Officer, stated, 'We are delighted to have David join the Immtech Board. His track record and extensive knowledge of the pharmaceutical industry make him an ideal addition to our team.'

Risk is the name of the game. If you can control it and manipulate it, the sky is the limit.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences